Table 4.
PSA50 Response Rate to Next-Line Therapy Based on Change in Clinical Practice After AR-V7 Testing
| Management | Did the Patient Achieve a PSA50 Response on Next-Line Therapy? | |||
|---|---|---|---|---|
| Yes | No | |||
| n/N | % | n/N | % | |
| Changed | 34/63 | 53.97 | 29/63 | 46.03 |
| Did not change | 16/52 | 30.77 | 36/52 | 69.23 |
NOTE. Fisher’s exact test P = .015.
Abbreviations: AR-V7, androgen receptor splice variant 7; n/N, number of patients in that category divided by total number of patients; PSA50, 50% decline in prostate-specific antigen.